Related Experiment Videos
A view on beta cell transplantation in diabetes
Daniel Pipeleers1, Bart Keymeulen, Lucienne Chatenoud
1Free University of Brussels (VUB), Brussels, Belgium. Daniel.Pipeleers@vub.ac.be
Annals of the New York Academy of Sciences
|May 22, 2002
Summary
Pancreas and islet cell transplantation show promise for treating diabetes by preventing complications. Inducing immune tolerance to donor cells is key for successful islet cell implants in patients.
Area of Science:
- Immunology
- Endocrinology
- Transplantation Medicine
Background:
- Organ donors provide insulin-producing islet cells for diabetes treatment.
- Transplantation aims to prevent diabetes complications without severe side effects.
Purpose of the Study:
- To discuss pancreas and islet cell transplantation for diabetes.
- To explore strategies for inducing immune tolerance to donor beta cells.
Main Methods:
- Review of clinical protocols and animal model progress.
- Limited study using antilymphocyte antibodies and cultured donor cells.
- Assessment of graft survival and immune reactivity in recipients.
Main Results:
- Cultured beta cell preparations enhance donor cell use and graft quality.
- Operational immune tolerance was indirectly observed in type 1 diabetic patients.
- Antilymphocyte antibodies and cell culture showed potential for tolerance induction.
Conclusions:
- Islet cell transplantation holds future potential for diabetes treatment.
- Achieving immune tolerance to donor beta cells is critical.
- Further development in beta cell neogenesis techniques is needed.